PRTN3 and rheumatoid arthritis: Jawbone loss has also been found increased in ACPA+ individuals before RA symptom onset (8), and higher prevalence of PD was reported for ACPA+ at-risk of RA individuals versus population controls (9, 10), implicating that PD may precede RA onset.